Monir Hossain
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Monir Hossain has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Awais Ashfaq
University of Cincinnati College of Medicine
3 shared publications - David Luis Simon Morales
University of Cincinnati College of Medicine
2 shared publications - Hosam F. Ahmed
NYU Langone Health New York City New York USA
2 shared publications - Kevin Kulshrestha
Department of Cardiothoracic Surgery, NYU Langone Health, New York, NY
2 shared publications - Yin Zhang
Emergency Medicine, Cincinnati Children's Hospital Medical Center, 3333 Burnet Ave, Cincinnati, OH, United States, 1 513-636-7966
2 shared publications Alan O’DOnnell
The Heart Institute, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio
1 shared publication
Latest Publications
- 13 August 2025
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 72 (4) , 333-340
Ex Vivo Hydrodynamic Assessment of Expanded Polytetrafluoroethylene Trileaflet Pulmonary Valves
Handmade trileaflet valves using expanded polytetrafluorethylene (ePTFE) have been considered a viable option for pulmonary valve replacement. Studies have performed ex vivo testing of adult sized valves, data on pediatric-sized ePTFE valves is limited. Our aim was to evaluate pediatric-sized ePTFE valves and ovine tissue valves as comparison to assess performance. Trileaflet valves were constructed using 0.1 mm ePTFE Gore-Tex membrane ranging from 14 to 20 mm in size and sutured into Hemashield conduits. Ovine pulmonary valves were harvested and ranged from 14 to 20 mm. Valves were tested under pediatric pulmonary conditions using a hydrodynamic tester. Regurgitation fraction (RF%), closing volume (CV%), closing volume duration (CVd, second), effective orifice area (EOA, cm 2 ), and peak pressure (PMax, mm Hg), and mean pressure (PMean, mm Hg) were measured. All valves reached goal cardiac output with mild regurgitation. Ovine pulmonary valves had significantly lower RF% than ePTFE valves (14 mm: 4.1 vs . 9.4%; 16 mm: 5.6 vs. 13.8%; 18 mm: 3.5 vs. 9.8%; 20 mm: 5.4% vs. 14.4%; p < 0.05, Table 3). Peak pressure was not significantly different between ovine versus ePTFE groups (14 mm: 37 vs. 24 mm Hg; 16 mm: 27 vs. 27 mm Hg; 18 mm: 26 vs. 27 mm Hg; 20 mm: 13 vs. 12 mm Hg). Expanded polytetrafluorethylene valves offer a viable option for pulmonary valve replacement given mild RF%, and comparable PMax. Further work is needed to understand the interplay between leaflet design and function.
- 13 August 2025
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 72 (4) , 333-340
Ex Vivo Hydrodynamic Assessment of Expanded Polytetrafluoroethylene Trileaflet Pulmonary Valves
Handmade trileaflet valves using expanded polytetrafluorethylene (ePTFE) have been considered a viable option for pulmonary valve replacement. Studies have performed ex vivo testing of adult sized valves, data on pediatric-sized ePTFE valves is limited. Our aim was to evaluate pediatric-sized ePTFE valves and ovine tissue valves as comparison to assess performance. Trileaflet valves were constructed using 0.1 mm ePTFE Gore-Tex membrane ranging from 14 to 20 mm in size and sutured into Hemashield conduits. Ovine pulmonary valves were harvested and ranged from 14 to 20 mm. Valves were tested under pediatric pulmonary conditions using a hydrodynamic tester. Regurgitation fraction (RF%), closing volume (CV%), closing volume duration (CVd, second), effective orifice area (EOA, cm 2 ), and peak pressure (PMax, mm Hg), and mean pressure (PMean, mm Hg) were measured. All valves reached goal cardiac output with mild regurgitation. Ovine pulmonary valves had significantly lower RF% than ePTFE valves (14 mm: 4.1 vs . 9.4%; 16 mm: 5.6 vs. 13.8%; 18 mm: 3.5 vs. 9.8%; 20 mm: 5.4% vs. 14.4%; p < 0.05, Table 3). Peak pressure was not significantly different between ovine versus ePTFE groups (14 mm: 37 vs. 24 mm Hg; 16 mm: 27 vs. 27 mm Hg; 18 mm: 26 vs. 27 mm Hg; 20 mm: 13 vs. 12 mm Hg). Expanded polytetrafluorethylene valves offer a viable option for pulmonary valve replacement given mild RF%, and comparable PMax. Further work is needed to understand the interplay between leaflet design and function.
- 1 January 2025
- Published by Oxford University Press (OUP) in Annals of the American Thoracic Society
- Vol. 22 (1) , 112-120
A Global Experience of Donation after Circulatory Death for Pediatric Lung Transplantation
Rationale: Donation after circulatory death (DCD) lung transplantation (LT) has increased, but there are limited data in children. Objectives: We sought to characterize the international experience of pediatric DCD LT in comparison with donation after brain death (DBD) to address extreme donor organ shortages in children needing LT. Methods: Using the International Society for Heart & Lung Transplantation Thoracic Organ Transplant Registry, 1,453 children (<18 yr of age) lung transplant recipients from January 2004 to June 2018 were identified: 34 (3%) were DCD and 1,419 (97%) were DBD recipients. Post-transplantation outcomes were compared between groups. The propensity score method was used to derive matched cohorts, which were compared between groups. Results: DCD and DBD recipients were of similar age, with cystic fibrosis being the most frequent indication for LT in both groups (64.5% vs. 57.5%, respectively). Kaplan-Meier analysis demonstrated similar survival between the DCD and DBD cohorts, whereas propensity score–matched recipients also identified similar post-transplantation survival in both groups (P = 0.098). Secondary analysis revealed that DCD lung transplant recipients had a longer post-transplantation length of hospital stay (unmatched cohorts, 36.5 vs. 20 d [P = 0.022]; matched cohorts, 26 vs. 19 d [P = 0.016]) and shorter time to acute cellular rejection (unmatched cohorts, 248 vs. 560 d [P = 0.039]; matched cohorts, 248 vs. 1,650 d [P = 0.059]). Conclusions: Because DCD is a key contributor to the increasing number of LTs being performed worldwide, the results of this analysis support this organ donation approach in children requiring LT, which would increase access to donor organs. The identification of a potential shorter time to acute cellular rejection needs further exploration as more DCD pediatric LTs are performed.
- 1 January 2025
- Published by Oxford University Press (OUP) in Annals of the American Thoracic Society
- Vol. 22 (1) , 112-120
A Global Experience of Donation after Circulatory Death for Pediatric Lung Transplantation
Rationale: Donation after circulatory death (DCD) lung transplantation (LT) has increased, but there are limited data in children. Objectives: We sought to characterize the international experience of pediatric DCD LT in comparison with donation after brain death (DBD) to address extreme donor organ shortages in children needing LT. Methods: Using the International Society for Heart & Lung Transplantation Thoracic Organ Transplant Registry, 1,453 children (<18 yr of age) lung transplant recipients from January 2004 to June 2018 were identified: 34 (3%) were DCD and 1,419 (97%) were DBD recipients. Post-transplantation outcomes were compared between groups. The propensity score method was used to derive matched cohorts, which were compared between groups. Results: DCD and DBD recipients were of similar age, with cystic fibrosis being the most frequent indication for LT in both groups (64.5% vs. 57.5%, respectively). Kaplan-Meier analysis demonstrated similar survival between the DCD and DBD cohorts, whereas propensity score–matched recipients also identified similar post-transplantation survival in both groups (P = 0.098). Secondary analysis revealed that DCD lung transplant recipients had a longer post-transplantation length of hospital stay (unmatched cohorts, 36.5 vs. 20 d [P = 0.022]; matched cohorts, 26 vs. 19 d [P = 0.016]) and shorter time to acute cellular rejection (unmatched cohorts, 248 vs. 560 d [P = 0.039]; matched cohorts, 248 vs. 1,650 d [P = 0.059]). Conclusions: Because DCD is a key contributor to the increasing number of LTs being performed worldwide, the results of this analysis support this organ donation approach in children requiring LT, which would increase access to donor organs. The identification of a potential shorter time to acute cellular rejection needs further exploration as more DCD pediatric LTs are performed.